Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Thomas A. Zelniker, Eugene Braunwald
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 4, pp. 422-434
Closed Access | Times Cited: 413
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S158-S190
Open Access | Times Cited: 327
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, et al.
Endocrine Practice (2022) Vol. 28, Iss. 10, pp. 923-1049
Open Access | Times Cited: 315
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S144-S174
Open Access | Times Cited: 165
Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study
Rozalina G. McCoy, Hayley J. Dykhoff, Lindsey R. Sangaralingham, et al.
Diabetes Technology & Therapeutics (2019) Vol. 21, Iss. 12, pp. 702-712
Open Access | Times Cited: 103
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Lactate accelerates vascular calcification through NR4A1-regulated mitochondrial fission and BNIP3-related mitophagy
Yi Zhu, Xiqiong Han, Xuejiao Sun, et al.
APOPTOSIS (2020) Vol. 25, Iss. 5-6, pp. 321-340
Closed Access | Times Cited: 76
FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress
Lin Chen, Yongzhen Guo, Yunlong Xia, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 160, pp. 27-41
Closed Access | Times Cited: 69
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
Chi‐Ho Lee, David Tak Wai Lui, Karen SL Lam
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 6, pp. 930-940
Open Access | Times Cited: 66
Silk Fibroin-Based Therapeutics for Impaired Wound Healing
Tanner Lehmann, Alyssa E. Vaughn, Sudipta Seal, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 651-651
Open Access | Times Cited: 56
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 14
Diabetes and Progression of Heart Failure
Justin B. Echouffo‐Tcheugui, Chiadi E. Ndumele, Sui Zhang, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 23, pp. 2285-2293
Open Access | Times Cited: 33
Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists
Giuliana Cimino, Muthiah Vaduganathan, Carlo Lombardi, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 2, pp. 649-661
Open Access | Times Cited: 21
Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis
Arif Albulushi, Desmond Boakye Tanoh, Ahmed Almustafa, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø Study
Hilde Espnes, Tom Wilsgaard, Jocasta Ball, et al.
JACC Advances (2025) Vol. 4, Iss. 2, pp. 101556-101556
Open Access
Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
BMP‑2 alleviates heart failure with type 2 diabetes mellitus and doxorubicin‑induced AC16 cell injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis
Jiamei Zhang, Rui-Qun Yu, Feng-Zhu Wu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 2
Open Access | Times Cited: 30
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease
P.M. Burger, Stefan Koudstaal, Jannick A N Dorresteijn, et al.
International Journal of Cardiology (2023) Vol. 379, pp. 66-75
Closed Access | Times Cited: 12
Association between endostatin and mortality in patients with acute dyspnoea, with or without congestive heart failure: a single-centre, prospective, observational study
Alireza Yaghoubi, Caroline Heijl, Ardavan Khoshnood, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e085238-e085238
Open Access
Addressing Comorbidities in Heart Failure
Aakash Bavishi, Ravi B. Patel
Heart Failure Clinics (2020) Vol. 16, Iss. 4, pp. 441-456
Open Access | Times Cited: 29
Clinical Benefits of Sodium–Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects
Yoshiaki Kubota, Wataru Shimizu
JACC Asia (2022) Vol. 2, Iss. 3, pp. 287-293
Open Access | Times Cited: 17
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus
Abeer Ahmed ALrefai, Heba F. Khader, Hany Abdelbary Abdelaziz Elbasuony, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6075-6085
Closed Access | Times Cited: 10
Myocardial Infarction
Mukesh Nandave
(2024), pp. 249-318
Closed Access | Times Cited: 3
Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa
Lebohang Pitso, Thabiso Rafaki Petrus Mofokeng, Riëtte Nel
BMC Endocrine Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top